The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
Self-citationCharbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Self-citationSaad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Self-citationA Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Self-citationRisk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
Self-citationLuckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
Self-citationRosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M. A., Coleman, R. E., Reitsma, D. J., et al. (2003) · Cancer · doi:10.1002/cncr.11701 · Cited by 873
Self-citationReduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
Diel, I. J., Solomayer, E.-F., Costa, S. D., Gollan, C., Goerner, R., Wallwiener, D., Kaufmann, M., & Bastert, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390601 · Cited by 809
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Rosen, L. S., Gordon, D., Tchekmedyian, N. S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2004) · Cancer · doi:10.1002/cncr.20308 · Cited by 705
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Lipton, A., Theriault, R. L., Hortobagyi, G. N., Simeone, J., Knight, R. D., Mellars, K., Reitsma, D. J., Heffernan, M., & Seaman, J. J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z · Cited by 665
Self-citationEndogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., & Ettinger, B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
SMITH, M. R., EASTHAM, J., GLEASON, D. M., SHASHA, D., TCHEKMEDYIAN, S., & ZINNER, N. (2003) · Journal of Urology · doi:10.1097/01.ju.0000063820.94994.95 · Cited by 650
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Self-citationTheriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Self-citationPaterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Self-citationKohno, N., Aogi, K., Minami, H., Nakamura, S., Asaga, T., Iino, Y., Watanabe, T., Goessl, C., Ohashi, Y., & Takashima, S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.116 · Cited by 546
Coleman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Self-citationRuggiero, S. L., Fantasia, J., & Carlson, E. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2006.06.004 · Cited by 507
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
Cramer, J. A., Gold, D. T., Silverman, S. L., & Lewiecki, E. M. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0322-8 · Cited by 443
Coleman, R. E., Banks, L. M., Girgis, S. I., Kilburn, L. S., Vrdoljak, E., Fox, J., Cawthorn, S. J., Patel, A., Snowdon, C. F., Hall, E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70003-7 · Cited by 426
Self-citationBody, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg367 · Cited by 413
Self-citationThe role of bisphosphonates in breast cancer: Development of bisphosphonates
Fleisch, H. (2001) · Breast Cancer Research · doi:10.1186/bcr414 · Cited by 407
Bisphosphonates: Preclinical Review
Green, J. R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-3 · Cited by 405
Bisphosphonates: Clinical Experience
Coleman, R. E. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-14 · Cited by 384
Self-citationHansen, T., Kunkel, M., Weber, A., & James Kirkpatrick, C. (2006) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2006.00391.x · Cited by 368
Renal Failure with the Use of Zoledronic Acid
(2003) · New England Journal of Medicine · doi:10.1056/nejm200310233491721 · Cited by 367
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 363
Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., & Schulman, K. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi122 · Cited by 362
Self-citationBisphosphonates for breast cancer
Pavlakis, N., & Stockler, M. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474 · Cited by 360
The acute-phase response after bisphosphonate administration
Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Lo Cascio, V. (1987) · Calcified Tissue International · doi:10.1007/bf02556671 · Cited by 357
Jagdev, S. P., Coleman, R. E., Shipman, C. M., Rostami-H, A., & Croucher, P. I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1727 · Cited by 346
Self-citationSmall, E. J., Smith, M. R., Seaman, J. J., Petrone, S., & Kowalski, M. O. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.147 · Cited by 341
Body, J. J., Diel, I. J., Lichinitzer, M., Lazarev, A., Pecherstorfer, M., Bell, R., Tripathy, D., & Bergstrom, B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601663 · Cited by 336
Self-citationRosen, L. S., Gordon, D. H., Dugan, W., Major, P., Eisenberg, P. D., Provencher, L., Kaminski, M., Simeone, J., Seaman, J., Chen, B., et al. (2004) · Cancer · doi:10.1002/cncr.11892 · Cited by 335
Self-citationGnant, M. F. X., Mlineritsch, B., Luschin-Ebengreuth, G., Grampp, S., Kaessmann, H., Schmid, M., Menzel, C., Piswanger-Soelkner, J. C., Galid, A., Mittlboeck, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7102 · Cited by 331
Self-citationMichaelson, M. D., Kaufman, D. S., Lee, H., McGovern, F. J., Kantoff, P. W., Fallon, M. A., Finkelstein, J. S., & Smith, M. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3361 · Cited by 330
Eastell, R., Hannon, R. A., Cuzick, J., Dowsett, M., Clack, G., & Adams, J. E. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060508 · Cited by 325
Brufsky, A., Harker, W. G., Beck, J. T., Carroll, R., Tan-Chiu, E., Seidler, C., Hohneker, J., Lacerna, L., Petrone, S., & Perez, E. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3744 · Cited by 321
Greenspan, S. L., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-6-200703200-00006 · Cited by 302
Bisphosphonates for the relief of pain secondary to bone metastases
Wong, R. K., & Wiffen, P. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002068 · Cited by 285
Delmas, P. D., Balena, R., Confravreux, E., Hardouin, C., Hardy, P., & Bremond, A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.955 · Cited by 278
Osteonecrosis of the Jaw — Do Bisphosphonates Pose a Risk?
Bilezikian, J. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068157 · Cited by 268
Friedlaender, G. E., Tross, R. B., Doganis, A. C., Kirkwood, J. M., & Baron, R. (1984) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198466040-00016 · Cited by 265
Ernst, D. S., Tannock, I. F., Winquist, E. W., Venner, P. M., Reyno, L., Moore, M. J., Chi, K., Ding, K., Elliott, C., & Parulekar, W. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.042 · Cited by 247
Bisphosphonates for breast cancer
Pavlakis, N., Schmidt, R. L., & Stockler, M. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474.pub2 · Cited by 244
Hewitt, R. E., Lissina, A., Green, A. E., Slay, E. S., Price, D. A., & Sewell, A. K. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02665.x · Cited by 241
Dearnaley, D. P. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg038 · Cited by 234
Daubine, F., Le Gall, C., Gasser, J., Green, J., & Clezardin, P. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk054 · Cited by 226
The skeletal metastatic complications of renal cell carcinoma
Zekri, J., Ahmed, N., Coleman, R., & Hancock, B. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.379 · Cited by 204
Self-citationBody, J.-J., Diel, I. J., Bell, R., Pecherstorfer, M., Lichinitser, M. R., Lazarev, A. F., Tripathy, D., & Bergström, B. (2004) · Pain · doi:10.1016/j.pain.2004.07.011 · Cited by 190
Self-citationWeitzman, R., Sauter, N., Eriksen, E. F., Tarassoff, P. G., Lacerna, L. V., Dias, R., Altmeyer, A., Csermak-Renner, K., McGrath, L., Lantwicki, L., et al. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.12.005 · Cited by 185
Oral clodronate in breast cancer patients with bone metastases: a randomized study
Kristensen, B., Ejlertsen, B., Groenvold, M., Hein, S., Loft, H., & Mouridsen, H. T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00507.x · Cited by 176
Brufsky, A., Bundred, N., Coleman, R., Lambert-Falls, R., Mena, R., Hadji, P., Jin, L., Schenk, N., Ericson, S., & Perez, E. A. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0206 · Cited by 175
Self-citationComparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy
Zojer, N., Keck, A. V., & Pecherstorfer, M. (1999) · Drug Safety · doi:10.2165/00002018-199921050-00004 · Cited by 167
Bisphosphonates for advanced prostate cancer
Yuen, K. K., Shelley, M., Sze, W. M., Wilt, T. J., & Mason, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006250 · Cited by 162
Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer
Cook, R. J., Coleman, R. E., Brown, J. E., Lipton, A., Major, P. P., Hei, Y. J., Fred Saad, C., & Smith, M. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0269 · Cited by 161
Self-citationPowles, T. J., Ashley, S., Tidy, V. A., Nevantaus, A., McCloskey, E., Kanis, J. A., Paterson, A. H. G., & Rosenqvist, K. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.704 · Cited by 159
Self-citationCooper, A., DRAKE, J., Brankin, E., & THE PERSIST INVESTIGATORS (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01059.x · Cited by 155
The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer
Delea, T. E., Langer, C. J., McKiernan, J., Liss, M., Edelsberg, J., Brandman, J., Sung, J., Raut, M. K., & Oster, G. (2004) · Oncology · doi:10.1159/000082923 · Cited by 155
Dunstan, C. R., Felsenberg, D., & Seibel, M. J. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0688 · Cited by 153
Wardley, A. M., Davidson, N. G. P., Barrett-Lee, P. J., Hong, A., Mansi, J., Dodwell, D. J., Murphy, R., Mason, T., & Cameron, D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602551 · Cited by 151
Neville-Webbe, H. L., Rostami‐Hodjegan, A., Evans, C. A., Coleman, R. E., & Holen, I. (2004) · International Journal of Cancer · doi:10.1002/ijc.20602 · Cited by 147
Self-citationClemons, M. J., Dranitsaris, G., Ooi, W. S., Yogendran, G., Sukovic, T., Wong, B. Y. L., Verma, S., Pritchard, K. I., Trudeau, M., & Cole, D. E. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9212 · Cited by 142
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
WYNGAERT, T. V. D., Huizing, M. T., & Vermorken, J. B. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl294 · Cited by 125
Bisphosphonates Are Incorporated into Adenine Nucleotides by Human Aminoacyl-tRNA Synthetase Enzymes
Rogers, M. J., Brown, R. J., Hodkin, V., Blackburn, G. M., Russell, R. G. G., & Watts, D. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1113 · Cited by 115
Heidenreich, A., Hofmann, R. W., & Engelmann, U. H. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00033 · Cited by 114
Weinfurt, K. P., Castel, L. D., Li, Y., Timbie, J. W., Glendenning, G. A., & Schulman, K. A. (2004) · Medical Care · doi:10.1097/01.mlr.0000108746.69256.45 · Cited by 111
Ernst, D. S., Brasher, P. M. A., Hagen, N. A., Paterson, A. H. G., MacDonald, R. N., & Bruera, E. D. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00075-4 · Cited by 105
Self-citationIbandronate in the treatment of prostate cancer associated painful osseous metastases
Heidenreich, A., Elert, A., & Hofmann, R. W. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500574 · Cited by 104
Lenz, J., Steiner-Krammer, B., Schmidt, W., Fietkau, R., Mueller, P. C., & Gundlach, K. K. H. (2005) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2005.07.007 · Cited by 93
Neville-Webbe, H. L., Evans, C. A., Coleman, R. E., & Holen, I. (2006) · Tumor Biology · doi:10.1159/000092489 · Cited by 91
Self-citationGoffinet, M., Thoulouzan, M., Pradines, A., Lajoie‐Mazenc, I., Weinbaum, C., Faye, J., & Séronie-Vivien, S. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-60 · Cited by 90
Gold, D. T., Safi, W., & Trinh, H. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154042 · Cited by 87
Improving Compliance and Persistence with Bisphosphonate Therapy for Osteoporosis
Emkey, R. D., & Ettinger, M. P. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.019 · Cited by 87
Zheng, Y., Zhou, H., Brennan, K., Blair, J. M., Modzelewski, J. R. K., Seibel, M. J., & Dunstan, C. R. (2007) · Bone · doi:10.1016/j.bone.2006.09.016 · Cited by 82
Vogel, C. L., Yanagihara, R. H., Wood, A. J., Schnell, F. M., Henderson, C., Kaplan, B. H., Purdy, M. H., Orlowski, R., Decker, J. L., Lacerna, L. V., et al. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-687 · Cited by 76
Fred Saad, C., Olsson, C. A., & Schulman, C. C. (2004) · European Urology · doi:10.1016/j.eururo.2004.08.016 · Cited by 71
Body, J. (2004) · Seminars in Nephrology · doi:10.1053/j.semnephrol.2003.08.015 · Cited by 69
Self-citationBreast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease
Body, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0840 · Cited by 68
Self-citationBotteman, M. F., Barghout, V. E., Stephens, J., Hay, J. W., Brandman, J., & Aapro, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl093 · Cited by 64
Self-citationBrufsky, A. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.022 · Cited by 64
Hirsh, V., Tchekmedyian, N. S., Rosen, L. S., Zheng, M., & Hei, Y.-J. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.n.030 · Cited by 63
Fred Saad, C. (2005) · Clinical Prostate Cancer · doi:10.3816/cgc.2005.n.009 · Cited by 63
Body, J. J., Lichinitser, M., Tjulandin, S. A., Garnero, P., & Bergstrom, B. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm119 · Cited by 52
Self-citationOral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma
Montazeri, A. H., Erskine, J. G., & McQuaker, I. G. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00872.x · Cited by 38
Bone loss induced by cancer treatment and its management
Delmas, P. D., & Fontana, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10135-6 · Cited by 34
Cock, E. D., Hutton, J., Canney, P. A., Body, J., Barrett-Lee, P. J., Neary, M. P., & Lewis, G. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.006 · Cited by 32
Self-citationTreatment of skeletal disease in breast cancer with clodronate
Paterson, A. H. G., Ernst, D. S., Powles, T. J., Ashley, S., McCloskey, E. V., & Kanis, J. А. (1991) · Bone · doi:10.1016/8756-3282(91)90063-o · Cited by 31
Self-citationQuality of Life and Symptom End Points in Palliative Bone Metastases Trials
Chow, E., Hoskin, P., van der Linden, Y. M., et al. (2005) · Clinical Oncology · doi:10.1016/j.clon.2005.06.016 · Cited by 27
Ibandronate in metastatic bone disease: a review of preclinical data
Bauss, F., & Body, J. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200502000-00001 · Cited by 24
Self-citationEfficacy of Ibandronate in Metastatic Bone Disease: Review of Clinical Data
Bell, R. H. (2005) · The Oncologist · doi:10.1634/theoncologist.10-90001-8 · Cited by 23
Higher persistency with i.v. bisphosphonates in patients with bone metastasis
Mangiapane, S., Höer, A., Gothe, H., Barghout, V. E., & Häussler, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.18623 · Cited by 22
Use of intravenous bisphosphonates in osteoporosis
Civitelli, R., Napoli, N., & Armamento‐Villareal, R. (2007) · Current Osteoporosis Reports · doi:10.1007/bf02938617 · Cited by 18
Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
Koka, S., Clarke, B. L., Amin, S., Gertz, M. A., & Ruggiero, S. L. (2007) · PubMed · Cited by 17
Statistical issues in quality-of-life assessment
Chow, S., & Fanny, Y. C. K. (1996) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409608835120 · Cited by 10
Journé, F., Magné, N., Chaboteaux, C., Kinnaert, E., Bauss, F., & Body, J. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9025-y · Cited by 10
Self-citationFred Saad, C. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.03.006 · Cited by 10
Cited by
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Algaba, F., Patard, J. J., Khoo, V., Eisen, T., & Horwich, A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu259 · Cited by 2,251
Witjes, J. A., Bruins, H. M., Cathomas, R., Compérat, E. M., Cowan, N. C., Gakis, G., Hernández, V., Linares Espinós, E., Lorch, A., Neuzillet, Y., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.03.055 · Cited by 2,017
Cornford, P., Bellmunt, J., Bolla, M., Briers, E., De Santis, M., Gross, T., Henry, A. M., Joniau, S., Lam, T. B., Mason, M. D., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.002 · Cited by 1,438
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Self-citationCornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.046 · Cited by 1,079
Metadata
- Authors
- Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F., & Thürlimann, B.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 19
- Issue
- 3
- Pages
- 420-432
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2152409486
- Cited by
- 457
- References
- 105
- FWCI
- 20.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.